Derek et al. [27] reported that knockdown of hepatic SirT1 increased STAT3 acetylation and STAT3 phosphorylation (Y705), thus decreased endogenous and insulin-stimulated glucose production and reduced fasting hyperglycaemia in a rat model of T2DM. The gene discussed is STAT3; the disease is type 2 diabetes mellitus.